Header cover image

Investing Ideas
/
Australian Pharmaceuticals & Biotech Potentially Undervalued Companies

Australian Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

38

0 new

Companies with a Value score of at least 3, ordered by Value score

38 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	MYXDA Mayne Pharma Group	AU$3.54	-9.2%	n/a	AU$305.4m	AU$5.28	PB0.5x	E73.5%	0%
	VIT Vitura Health	AU$0.097	10.2%	-82.0%	AU$55.3m	n/a	PE5.9x	n/a	10.3%
	MSB Mesoblast	AU$1.10	16.5%	-9.1%	AU$1.3b	AU$1.10	PS112.8x	E48.8%	n/a
	TLX Telix Pharmaceuticals	AU$18.00	-1.9%	62.7%	AU$6.0b	AU$18.89	PE190.2x	E35.7%	n/a
	MDC Medlab Clinical	AU$6.60	0%	-43.6%	AU$15.1m	n/a	PS9.8x	E-44.7%	n/a
	CUV Clinuvel Pharmaceuticals	AU$14.58	-4.5%	-17.6%	AU$776.7m	AU$30.32	PE24.2x	E26.7%	0.3%
	AFP AFT Pharmaceuticals	NZ$2.81	-1.4%	-17.4%	NZ$304.1m	NZ$3.45	PE20.5x	E18.1%	0.5%
	VLS Vita Life Sciences	AU$2.21	0.5%	41.2%	AU$123.3m	n/a	PE13.7x	n/a	4.1%
	CSL CSL	AU$295.13	1.1%	11.4%	AU$142.8b	AU$305.16	PE39.3x	E13.6%	1.2%
	CSL CSL	AU$298.53	2.2%	12.6%	AU$142.8b	AU$308.67	PE39.3x	E13.6%	1.2%
	MYX Mayne Pharma Group	AU$4.26	-3.4%	-3.4%	AU$347.3m	AU$6.89	PS1.1x	E99.8%	n/a
	MYX Mayne Pharma Group	AU$4.28	-2.9%	-2.3%	AU$347.3m	AU$6.92	PS1.1x	E99.8%	n/a
	CUV Clinuvel Pharmaceuticals	AU$15.60	2.1%	-11.6%	AU$776.7m	AU$32.44	PE24.2x	E26.7%	0.3%
	VLS Vita Life Sciences	AU$2.20	0%	40.6%	AU$123.3m	n/a	PE13.7x	n/a	4.1%

Page 2 of 2